ROSG - Rosetta Genomics Ltd.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue2,0392,8751,327405
Cost of Revenue1,5411,0031,310709
Gross Profit4981,87217-304
Operating Expenses
Research Development3,1562,9561,9271,744
Selling General and Administrative9,97712,01512,34211,299
Non Recurring----
Others----
Total Operating Expenses14,67415,97415,57913,752
Operating Income or Loss-12,635-13,099-14,252-13,347
Income from Continuing Operations
Total Other Income/Expenses Net-583-1,429-259177
Earnings Before Interest and Taxes-12,635-13,099-14,252-13,347
Interest Expense-595-588-39-15
Income Before Tax-13,218-14,528-14,511-13,170
Income Tax Expense-341915-
Minority Interest----
Net Income From Continuing Ops-13,184-14,547-14,526-13,170
Non-recurring Events
Discontinued Operations-3,049-2,798-2,798273
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,233-17,345-14,526-12,897
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,233-17,345-14,526-12,897